Intracellular Trapping of the Selective Phosphoglycerate Dehydrogenase (PHGDH) InhibitorBI-4924Disrupts Serine Biosynthesis.
Weinstabl, H., Treu, M., Rinnenthal, J., Zahn, S.K., Ettmayer, P., Bader, G., Dahmann, G., Kessler, D., Rumpel, K., Mischerikow, N., Savarese, F., Gerstberger, T., Mayer, M., Zoephel, A., Schnitzer, R., Sommergruber, W., Martinelli, P., Arnhof, H., Peric-Simov, B., Hofbauer, K.S., Garavel, G., Scherbantin, Y., Mitzner, S., Fett, T.N., Scholz, G., Bruchhaus, J., Burkard, M., Kousek, R., Ciftci, T., Sharps, B., Schrenk, A., Harrer, C., Haering, D., Wolkerstorfer, B., Zhang, X., Lv, X., Du, A., Li, D., Li, Y., Quant, J., Pearson, M., McConnell, D.B.(2019) J Med Chem 62: 7976-7997
- PubMed: 31365252 
- DOI: 10.1021/acs.jmedchem.9b00718
- Primary Citation of Related Structures:  
6CWA, 6RIH, 6RJ6, 6RJ3, 6RJ2, 6RJ5 - PubMed Abstract: 
Phosphoglycerate dehydrogenase (PHGDH) is known to be the rate-limiting enzyme in the serine synthesis pathway in humans. It converts glycolysis-derived 3-phosphoglycerate to 3-phosphopyruvate in a co-factor-dependent oxidation reaction. Herein, we repor ...